Monthly Archives: November 2016

Top 5 Communications Equipment Stocks To Own Right Now

Related JPM How Long Will This Trading Range Persist? JPMorgan Rallies Ahead Of Q1 Report Dismal Earnings Outlook Projected for 1st Quarter (GuruFocus) Related PIR Benzinga's Top Initiations Mid-Afternoon Market Update: Crude Oil Up 5%; Pier 1 Imports Shares Spike Higher The Vetr community has downgraded $PIR to 1.5-Stars (Vetr)

JPMorgan Chase & Co. (NYSE: JPM) is estimated to report its quarterly earnings at $1.26 per share on revenue of $23.40 billion.

Top 5 Communications Equipment Stocks To Own Right Now: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts expect Lightinthebox Holding Co Ltd-ADR (NYSE: LITB) to report a quarterly loss at $0.05 per share on revenue of $66.83 million. Lightinthebox shares gained 0.62 percent to close at $2.66 on Friday.

  • [By Monica Gerson]

    Lightinthebox Holding Co Ltd-ADR (NYSE: LITB) is expected to report a quarterly loss at $0.05 per share on revenue of $66.83 million.

    Digital Turbine Inc (NASDAQ: APPS) is projected to post a quarterly loss at $0.08 per share on revenue of $23.00 million.

Top 5 Communications Equipment Stocks To Own Right Now: Molson Coors Brewing Company(TAP)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Redbook Reports US Retail Sales During October Down 0.1% MoM, Up 0.6% YoY

    Data on motor vehicle sales for October will be released today. The Federal Open Market Committee will begin two-day policy meeting today. The Markit manufacturing PMI for October will be released at 9:45 a.m. ET. The ISM manufacturing index for October is schedule for release at 10:00 a.m. ET. Data on construction spending for September will be released at 10:00 a.m. ET. The Treasury is set to auction 4-week bills at 11:30 a.m. ET. BZ News Desk Focus Pfizer (NYSE: PFE) Q3 EPS $0.61 vs $0.62 Est., Revenue $13.05B vs $13.05B Est. Royal Dutch Shell Q3 EPS $0.35 vs $0.44 Est., Revenue $61.9B vs $61.1B Est. Coach (NYSE: COH) Q1 EPS $0.45 vs $0.45 Est., Revenue $1.04B vs $1.07B Est. Molson Coors (NYSE: TAP) Q3 EPS $1.03 vs $1.12 Est., Revenue $2.29B vs $2.33B Est. Sell-Side Themes

    Camping World's (NYSE: CWH) analyst quiet period has ended. So far, it has received coverage form four analysts.

  • [By Jon C. Ogg]

    We are resuming coverage of Molson Coors (TAP) with a Buy rating and $140 price objective. Our price objective applies a 20.9x P/E multiple to our 2017 estimated pro-forma cash earnings per share of $6.68. We expect Miller Coors/Miller international integration to catalyze sales growth and expanded margins & free cash flow.

Top 5 Communications Equipment Stocks To Own Right Now: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By Igor Greenwald, Financial Columnist, The Energy Strategist]

    Oaktree Capital Group (OAK) raises most of the funds it invests in companies, credit, and real estate from institutional investorsincluding public pension fundsand charges them hedge-like fees for the privilege.

Top 5 Communications Equipment Stocks To Own Right Now: Stage Stores, Inc.(SSI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Stage Stores Inc (NYSE: SSI) shares fell 15.11 percent to $5.00 in pre-market trading after the company reported weaker-than-expected Q1 results and lowered its full-year outlook.

Top 5 Communications Equipment Stocks To Own Right Now: Amira Nature Foods Ltd(ANFI)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another earnings short-squeeze prospect is packaged specialty rice and other food products distributor Amira Nature Foods (ANFI), which is set to release numbers on next Monday after the market close. Wall Street analysts, on average, expect Amira Nature Foods to report revenue of $132.37 million on earnings of 32 cents per share.

    The current short interest as a percentage of the float for Amira Nature Foods is extremely high at 26.6%. That means that out of 17.70 million shares in the tradable float, 4.72 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 8.2%, or by 356,000 shares. If the bears get caught pressing their bets into a bullish quarter, then shares of ANFI could easily rip sharply higher post-earnings as the shorts move fast to cover some of their trades.

    From a technical perspective, ANFI is currently trending above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock just recently bounced higher off some near-term support at $15.25 a share. That bounce is starting to push shares of ANFI within range of triggering a near-term breakout trade post-earnings.

    If you’re bullish on ANFI, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $17 to $17.98 a share and then above more resistance at $18.52 a share with high volume. Look for volume on that move that registers near or above its three-month average action of 174,102 shares. If that breakout develops post-earnings, then ANFI will set up to re-test or possibly take out its next major overhead resistance levels at $19.86 to $20.29 a share, or even its 52-week high at $25 a share.

    I would simply avoid ANFI or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below some key near-term supp

Hot Promising Stocks To Buy Right Now

U.S. equities are soaring Monday, after the FBI confirmed over the weekend it has no new evidence that implicates Hillary Clinton in the FBI’s investigation of her use of a private email server as Secretary of State.

When the news broke, the Dow Jones Industrial Average jumped more than 250 points while the S&P 500 and Nasdaq indices each gained more than 1.50 percent. Needless to say, investors are assuming that the FBI's update all but guarantees a Clinton victory, which is generally considered to be the safer outcome for stocks.

Among the top gaining sectors is financials, with The Financial Select Sector SPDR Fund (NYSE: XLF) rising by more than 2 percent. Technology and energy stocks also traded stronger.

Selling Opportunity?

Dennis Dick, co-host of Benzinga's daily PreMarket Prep show, pointed out during Monday's show that investors and portfolio managers nervous heading into the election could find Monday's surge the ideal opportunity to sell into strength.
"Is this not the best selling opportunity that you can get?" Dick asked. "You are going to have multiple stocks hitting 52-week highs – a lot of the banks, financials are right near 52-week highs this morning."
Dick added that investors shouldn't be surprised if the markets experience some selling pressure as more and more investors decide to de-risk their portfolio or simply take some profits off the table.

Hot Promising Stocks To Buy Right Now: MGC Diagnostics Corporation(MGCD)

Advisors’ Opinion:

  • [By Monica Gerson]

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

    Lands’ End, Inc. (NASDAQ: LE) is estimated to report its quarterly earnings at $0.02 per share on revenue of $293.24 million.

Hot Promising Stocks To Buy Right Now: Inphi Corporation(IPHI)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Inphi (IPHI) provides high-speed analog and mixed signal semiconductor solutions for the communications, datacenter and computing markets. This stock closed up 4.7% at $13.25 in Monday’s trading session.

    Monday’s Volume: 838,000

    Three-Month Average Volume: 202,080

    Volume % Change: 378%

    From a technical perspective, IPHI jumped higher here right above some near-term support at $12.44 with heavy upside volume. This stock has been uptrending strong for the last five months, with shares soaring higher from its low of $8.62 to its intraday high of $13.85. During that uptrend, shares of IPHI have been consistently making higher lows and higher highs, which is bullish technical price action. That move briefly pushed shares of IPHI into breakout territory, since the stock flirted with some near-term overhead resistance at $13.50.

    Traders should now look for long-biased trades in IPHI as long as it’s trending above some near-term support at $12.44 and then once it sustains a move or close above its new 52-week high at $13.85 with volume that hits near or above 202,080 shares. If we get that move soon, then IPHI will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are its next major overhead resistance levels at $14.79 to $16.94, or possibly even $18.

Hot Promising Stocks To Buy Right Now: Oxford Industries Inc.(OXM)

Advisors’ Opinion:

  • [By Mike Deane]

    After the bell on Tuesday, Oxford Industries (OXM) announced its second quarter earnings, posting a 14% increase in net sales from last year’s same quarter.

    The Atlanta, GA-based apparel company announced second quarter consolidated net sales of $235 million, which were up from last year’s Q2 figure of $206.9 million. The company’s EPS, on an adjusted basis, came in at $1.01, a 55% increase from last year’s 65 cents.

    Oxford Industries beat analysts’ Q2 EPS estimates of 98 cents, but missed the analyst revenue consensus of $243.5 million.

    Looking forward to full-year 2013, Oxford Industries lowered its EPS guidance to a range of $2.90 to $3.05. This comes in below the analysts’ consensus of $3.12.

    OXM shares were up 86 cents, or 1.33%, at the end of trading on Tuesday. YTD the stock is up more than 40%.

  • [By Roberto Pedone]

    One potential earnings short-squeeze candidate is men’s apparel products player Oxford Industries (OXM), which is set to release numbers Tuesday after the market close. Wall Street analysts, on average, expect Oxford Industries to report revenue of $243.48 million on earnings of 98 cents per share.

    If this company can manage to beat or meet Wall Street’s earnings estimates this quarter, then it would mark the biggest quarterly gain in the last six quarter.

    The current short interest as a percentage of the float for Oxford Industries is not able at 5.7%. That means that out of the 14.31 million shares in the tradable float, 817,000 shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 3.8%, or by about 29,000 shares. If the bears are caught being too aggressive into a solid quarter, then shares of OXM could soar higher post-earnings as the bears rush to cover some of their bets.

    From a technical perspective, OXM is currently trending above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock recently sold off hard from its August high of $69.29 to its low of $61.10 with higher-than-average volume flows. Shares of OXM have now started to rebound a bit off that low of $61.10 with strong upside volume flows. That move is quickly pushing shares of OXM within range of triggering a near-term breakout trade.

    If you’re bullish on OXM, then I would wait until after its report and look for long-biased trades if this stock manages to break out above its 50-day moving average at $65.77 a share to more resistance at $65.93 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 103,286 shares. If that breakout triggers, then OXM will set up to re-test or possibly take out its 52-week high at $69.28 a share. Any high-volume move above that level will then give OXM a chance t

  • [By Ben Levisohn]

    Not investors in Restoration Hardware (RH). Its shares have dropped 2% in after-hours trading after it reported a profit of 49 cents a share, above forecasts for 43 cents, but offered mixed guidance. Oxford Industries (OXM) is off 7.3% at $60 after it announced a profit of $1.01, ahead of 98 cents consensus forecasts, but lowered its 2013 guidance. Shares of SunEdison (SUNE) have dropped 5.4% to $7.90 after it announced a secondary offering.

Hot Promising Stocks To Buy Right Now: Zumiez Inc.(ZUMZ)

Advisors’ Opinion:

  • [By Chris Lange]

    Zumiez Inc. (NASDAQ: ZUMZ) is set to report its fiscal second-quarter results on Thursday. The consensus estimates predicta net loss of $0.08 per share and $177.35 million in revenue. Shares were changing hands at $16.61 on Fridays close. The consensus price target is $15.20, and the stock has a 52-week range of $11.53 to $23.45.

Hot Promising Stocks To Buy Right Now: Dynamic Materials Corporation(BOOM)

Advisors’ Opinion:

  • [By Andrew Efimoff]

    WTI crude oil plunged 3.11 percent on Friday to $48.99 a barrel. Below are the biggest energy losers for the day:

    California Resources Corporation (NYSE: CRC): -19.22% Dynamic Materials (NASDAQ: BOOM): -12.39% Clayton Williams Energy (NYSE: CWEI): -11.45% Dynergy (NYSE: DYN): -11.91% EP Energy Corporation (NYSE: EPE): -11.20% Mexco Energy (NYSE: MXC) -10.90% Whiting Petroleum (NYSE: WLL) -10.79% Southwestern Energy Company (NYSE: SWN) -10.79% SM Energy Company (NYSE: SM) -10.38% Real Goods Solar (NASDAQ: RGSE) -10.34%

    Posted-In: Commodities After-Hours Center Markets Movers

Hot Promising Stocks To Buy Right Now: Maxwell Technologies, Inc.(MXWL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Maxwell Technologies (NASDAQ: MXWL) surged 9.20% to $10.21. The volume of Maxwell Technologies shares traded was 325% higher than normal. Maxwell’s trailing-twelve-month revenue is $190.57 million.

Top 5 Freight Companies To Invest In Right Now

American Express (AXP) has jumped 9% today after reporting better-than-expected earnings, and since it’s a component of the Dow Jones Industrial Average, you’d expect the blue-chip benchmark to be soaring. You’d be wrong, thanks toTravelers Companies (TRV), which has tumbled 5.2% after reporting earnings of its own.

Agence France-Presse/Getty Images

Now Travelers has a market cap of $33.2 billion, compared to American Express’ $56.6 billion market capitalization. The Dow, however, is price weighted, which means that the higher the price, the greater the stock weighting. American Express is trading at $66.77, while Travelers is trading at $110.22. That makes the move in Travelers count nearly twice as much as the one in American Express. Travelers has subtracted 41.16 points from the Dow Jones Industrial Average, while American Express has added 37.80 points.

Top 5 Freight Companies To Invest In Right Now: Zions Bancorporation(ZION)

Advisors’ Opinion:

  • [By Monica Gerson]

    Zions Bancorporation (NASDAQ: ZION) is estimated to post its quarterly earnings at $0.39 per share on revenue of $576.49 million. Zions Bancorporation shares gained 2.10 percent to close at $27.28 on Friday.

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

  • [By Jon C. Ogg]

    In the super-regional banks that are not money center banks, Regions Financial Corp. (NYSE: RF) was up 6.3% at $13.22, and Zions Bancorporation (NASDAQ: ZION) was last seen up 3.8% at $38.30. They would both do better with lower regulatory costs and be able to better compete against larger banks when their stress test results had not been as strong.

  • [By Ben Levisohn]

    Who will have the most incremental capital return? We would highlight Zions Bancorporation (ZION), Citigroup, Bank of America, and M&T Bank (MTB) as the CCAR banks that we expect to post the most material year-to-year increase in capital return in CCAR 2016.

  • [By Monica Gerson]

    Zions Bancorporation (NASDAQ: ZION) is projected to post its quarterly earnings at $0.39 per share on revenue of $576.49 million.

    Crane Co. (NYSE: CR) is expected to post its quarterly earnings at $0.86 per share on revenue of $644.60 million.

Top 5 Freight Companies To Invest In Right Now: Leucadia National Corporation(LUK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

  • [By Ben Levisohn]

    We delved into Kraft Heinz’s (KHC) earnings beat, and explained the impact of Leucadia National’s (LUK) investment in National Beef on its earnings.

  • [By Michael Hooper]

    When compared with similar companies, Berkshire Hathaway carries a premium over Markel (NYSE: MKL  ) , valued at 1.15 times book value and a 20 forward P/E ratio; and Leucadia National (NYSE: LUK  ) , valued at 1.10 times book value and a 7.16 trailing P/E.

Top 5 Freight Companies To Invest In Right Now: CBOE Holdings Inc.(CBOE)

Advisors’ Opinion:

  • [By CNNMoney Staff]

    Stocks continued to rally despite the fact that options trading was temporarily halted Monday afternoon at exchanges run by CBOE Holdings (CBOE), Nasdaq OMX (NDAQ), BATS Global Markets and Miami International Holdings due to issues at the Options Price Reporting Authority (OPRA), which provides trading data and price quotes.

  • [By Saumya Vaishampayan var popups = $(“.socialByline .popC”); ]

    Those who dabble in derivatives tied to the CBOE (CBOE) Volatility Index are placing bets that pay out if the stock market keeps swinging, and especially if it drops.

Top 5 Freight Companies To Invest In Right Now: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By Matthew Briar]

    Earlier this week, Vitality Biopharma Inc (OTCMKTS:VBIO) threw its hat into the opioid-replacement ring, pointing out its work with the highly-flexible cannabis plant could easily be applied to kill severe pain. As Vitality Biopharma CEO Robert Brooke put it, “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

    It couldn’t have been better scripted for VBIO shareholders. On Friday of this week, Fox News posted “Medical marijuana programs may help cut opioid use,” underscoring many of the things Brooke pointed out.

    The Fox News commentary served up some encouraging statistics on the potential of medical marijuana and cannabis as an alternative pain treatment. Specifically, the article recited data from a contribution to the American Journal of Public Health, saying “The researchers found that the rates of opioid use decreased in adults ages 21 to 40 in states that had legalized medical marijuana and where residents with prescriptions could obtain cannabis from dispensaries or grow their own, compared to states that had legalized medical marijuana but did not yet have an operational program for people to obtain it.”

    It points to the distinct reality that (1) not every opioid user want to use it, and (2) there’s a pain-killing upside to medical marijuana. And it’s worth noting the research focused on the more traditional forms of medical marijuana, and not as a prescription-dispended pill or injection. In a more refined form, it may offer treatment options for an even greater number of people.

    At the heart of Vitality Biopharma’s future – and pipeline – is a superior science.

    In short, the same basic molecular formula that makes cannabis an incredibly useful basis for drug creation is made even bett

  • [By Matthew Briar]

    When many investors think of medical marijuana — real cannabinoid drugs as opposed to a food or drink with some sort of marijuana plant listed as an ingredient — companies like GW Pharmaceuticals PLC (NASDAQ:GWPH) and Insys Therapeutics Inc (NASDAQ:INSY) come to mind. That’s not unreasonable. Insys Therapeutics’ dronabinol oral solution, Syndros(tm), is the first FDA- approved orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol… a pharmaceutical version of tetrahydrocannabinol (“THC”). Syndros treats anorexia-driven weight loss for AIDS patients. n the meantime, GW Pharmaceuticals’ cannabinoid-based Sativex has already been approved in several countries as a way of reducing muscle spasticity for multiple sclerosis patients. It’s also being tried as a pain-control drug for cancer patients, demonstrating not just the efficacy of cannabinoids, but the diversity of what the can do.

    Each company’s portfolio and pipeline are promising, as are cannabinoids in general. A yound and hungry outfit called Vitality Biopharma Inc (OTCMKTS:VBIO), though, may take the science of cannabinoid to the next proverbial level.

    Vitality Biopharma’s work so far has aimed to make cannabidiol the next generation of cannabinoid drugs.

    Cannabidiol is a non-psychotropic (meaning it doesn’t get you “high) form of cannabis, and has demonstrated therapeutic effects for major neurological conditions like rare seizure disorders, and also as a way of treating symptoms of multiple sclerosis. Vitality Biopharma’s prodrugs [drugs that are converted into their effective form after being processed in the body] could exert the same therapeutic effects. But, Vitality’s drugs could do this better than most cannabinoids currently do.

    How so? Broadly speaking, and as was noted, Vitality Biopharma’s work to-date has focused on turning cannabidiol into a prodrug, or a drug that doesn’t become its final, active form until it’s

  • [By James E. Brumley]

    When most most investors thik of medical marijuana — actual cannabinoid drugs rather than just an edible that names marijuana plant as an ingredient — companies like GW Pharmaceuticals PLC (NASDAQ:GWPH) and Insys Therapeutics Inc (NASDAQ:INSY) come to mind. And, that’s largely as it should be. Insys Therapeutics’ dronabinol oral solution, Syndros(tm), is the FDA’s first-ever approved orally-administered liquid formula of the pharmaceutical cannabinoid dronabinol, which is a pharmaceutical version of tetrahydrocannabinol (“THC”). (Syndros treatment for anorexia-driven weight loss in patients with AIDS.) And, GW Pharmaceuticals’ cannabinoid-based Sativex is already approved in several countries as a means of controlling muscle spasticity for multiple sclerosis patients. It’s also being tried as a means of pain-control in cancer patients.

    Both companies’ portfolios and pipelines are promising, as are cannabinoid in general. An up-and-coming company called called Vitality Biopharma Inc (OTCMKTS:VBIO), however, may well take the science of cannabis to a whole new level.

    Vitality Biopharma’s work so far has been focused on the use of cannabidiol as a means of creating better drugs.

    Cannabidiol is a non-psychotropic derivative of cannabis, which has shown therapeutic effects for serious neurological conditions including rare seizure disorders, and for alleviating symptoms of multiple sclerosis. Vitality Biopharma’s prodrugs (drug that are converted into their effective form after being processed in the body) could exert the same beneficial therapeutic effects. Howver, they could do so better than most rival cannabinoid drugs do.

    How so? Part of the overarching answer is, Vitality Biopharma’s work has been in turning cannabidiol into a prodrug. This allows for targeted delivery within the body, even to the brain. Perhaps the biggest edge cannabidiol-based drugs have over cannabinoids, though, is that they’re non-psychotr

  • [By James E. Brumley]

    In mid-September, Vitality Biopharma Inc (OTCMKTS:VBIO) announced it was going to take aim at the development of an alternative to opioids as a means of treating pain. At the time, there was little doubt that the company’s cannabinoid science was capable of doing so. What wasn’t clear to VBIO shareholders was exactly how that might happen…. meaning what sort of drug might Vitality Biopharma come up with.

    We got the first of what will likely be several answers to the question today. Per today’s press release, Vitality Biopharma intends to come up with a treatment for narcotic bowel syndrome, which is a severe form of (ironically enough) opiate-induced abdominal pain.

    As a refresher, Vitality Biopharma was the name we introduced to you back on August 8th, pointing out it had developed a whole new way of making cannabinoid-based medicines. Their versions offer all the upsides of cannabinoids, but without the psychotropic (“getting high’) effects, and without some of the common downsides associated with these pharmaceuticals… like mouth and skin lesions.

    There are even bigger advantages to Vitality Biopharma’s science, however. Namely, since these drugs are prodrugs and aren’t activated until in the body, they allow for targeted delivery to the GI tract (yet can also selectively target other body parts, even as far away from the GI tract as the brain). Perhaps more than anything though, these drugs are orally-administered by virtue of being highly soluble, making them easy to use.

    It’s this nuance that makes Vitality Biopharma’s recently-announced intention so interesting, and compelling.

    Studies have found that up to 81% of patients treated with opiates have functional bowel disorders, with more than half — 58% to be exact — of opiate users reporting chronic abdominal pain stemming from the use of their prescribed painkillers. Considering 200 million opioid prescriptions are filled every year in the United States alo

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Bryan Murphy]

    In early September, Vitality Biopharma Inc (OTCMKTS:VBIO) unofficially entered the opioid-replacement race when CEO Robert Brooke highlighted the company’s work that could turn the highly-flexible cannabis plant into a drug that could treat severe pain just as well as opioids could. As Brooke explained it, “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

Top 5 Freight Companies To Invest In Right Now: Westar Energy, Inc.(WR)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Thursday, utilities shares rose by 0.02 percent. Top gainers in the sector included Westar Energy Inc (NYSE: WR), Westar Energy Inc (NYSE: AT), and NRG Energy Inc (NYSE: NRG).

  • [By Jayson Derrick]

    According to a report by Bloomberg, Westar Energy Inc (NYSE: WR) is a potential takeover target from rival Ameren Corp (NYSE: AEE) and a consortium of investors, including Toronto-based Borealis Infrastructure Management and the Canada Pension Plan Investment Board.

Hot Growth Companies For 2017

The Internet of Things (“IoT”) has received a lot of attention over the last few years as a potentially explosive growth area, but so far has been a disappointment to many early investors.

Sierra Wireless (NASDAQ:SWIR) has been the poster child for the IoT since being obscenely hyped by “The Motley Fool” in 2013 and 2014 with phrases like “89X Your Money By 2020” and “$19 TRILLION SECRET HIDING IN BILL GATES’ MANSION”.

The result was a huge bubble in the stock by late 2014, before bursting and giving SWIR investors and IoT a black eye. The decline in SWIR stock price was further accentuated by 3 quarters in a row of YoY decreasing revenues from 2015 Q3 – 2016 Q2.

Hot Growth Companies For 2017: Intuitive Surgical Inc.(ISRG)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Microsoft (NASDAQ: MSFT) Reports Q4 EPS $0.69 vs. Est. $0.58, Rev. $22.64B vs. Est. $22.14B
    Intuitive Surgical (NASDAQ: ISRG) Reports Q2 GAAP EPS $4.71, Adj. EPS $5.62 vs $4.97 Est., Sales $670.1M vs $540.7M Est.
    Halliburton (NYSE: HAL) Q2 EPS ($0.14) vs ($0.19) est, Revenue $3.84B vs $3.75B est
    Morgan Stanley (NYSE: MS) Q2 EPS $0.75 vs $0.59 est, Revenue $8.9B vs $8.3B est

  • [By Joseph Hogue]

    Enter Intuitive Surgical (Nasdaq: ISRG) and Da Vinci, a robotic arm that allows surgeons to operate with just a single incision less than an inch in size.

Hot Growth Companies For 2017: Buffalo Wild Wings Inc.(BWLD)

Advisors’ Opinion:

  • [By AnnaLisa Kraft]

    A chicken-wing upstart
    But with success comes competition.McDonald’s (NYSE: MCD  ) is debuting its own Mighty Wings nationally, chicken wings seasoned similarly to Popeye’s New Orleans style with cayenne and chili pepper. The huge quantity of wings that McDonald’s will need likely driving up prices from $1.44 a pound most recently will of course, affect the entire space including Yum! Brands, AFCE, and chicken focused Buffalo Wild Wings (NASDAQ: BWLD  )

  • [By Lisa Levin]

    Shares of Buffalo Wild Wings (NASDAQ: BWLD) were down 12 percent to $127.89 as the company reported weaker-than-expected results for its first quarter on Tuesday.

  • [By Lisa Levin]

    Shares of Buffalo Wild Wings (NASDAQ: BWLD) were down 13 percent to $125.18 as the company reported weaker-than-expected results for its first quarter on Tuesday.

  • [By Hilary Kramer]

     We welcome host of Fox Business Network’s Making Money with Charles Payne to this year’s contest. When he’s not on air, the rags-to-riches financial guru is editing his free weekly newsletter, Charles Payne’s Smart Talk, as well as his new newsletter, Charles Payne’sSmart Investing, which allows individuals insights into picks that were formerly only available to institutions.

    Payne is going with the owner, operator and franchiser of a wildly popular sports and wings bar for this year’s pick: Buffalo Wild Wings (BWLD).

    With commodities prices in the dumps, BWLD stands to benefit as Americans have more cash lining their pockets thanks to lower gas prices. That’s cash, Charles reasons, that Buffalo Wild Wings will be able to claim a chunk of. Not to mention the fact that if chicken prices remain subdued, it’ll mean a beefier bottom line.

  • [By CNBC]

    Tony Tribble, Invision/AP Forget about Bloomin’ Onions or boneless wings, for many consumers, the choice of where to dine often comes down to a different factor: which restaurant has the best booze. “Alcoholic beverages can be a key driver of traffic, differentiation, and loyalty,” said David Decker, president of Consumer Edge Insight. According to the firm, two factors that keep customers coming back are “selection” and “pricing.” Consumer Edge Insight recently surveyed restaurant customers to find out which casual-dining spots generated the most loyalty with their alcoholic beverages. Taking the top spot for “selection” was Buffalo Wild Wings (BWLD), with 29 percent of those surveyed saying they were “most likely to visit it most often due to its good selection of alcoholic beverages.” Applebee’s (DIN) took the second spot, with 24 percent, and Outback Steakhouse (BLMN) and T.G.I. Friday’s tied for third place with 22 percent each. Prices also keep customers coming back to Buffalo Wild Wings. When asked which casual-dining brand they were “most likely to visit most often due to its good prices of alcoholic beverages,” Buffalo Wild Wings came out on top with 30 percent. Chili’s (EAT) was No. 2 at 23 percent, and Ruby Tuesday (RT) was third with 22 percent. Buffalo Wild Wings has always made alcohol a part of its experience, even making it part of its tagline: “Wings.Beer.Sports.” The chain is the No. 1 account for more than 50 different beer brands and recently launched Game Changer, a new beer in a partnership with Redhook Brewery. Priced between cheaper domestic lagers and pricier craft beers, Game Changer became the fourth-most-popular draft beer at company-owned locations within two weeks of its release. “Among casual-dining restaurants, Buffalo Wild Wings is seeing the greatest positive effect in terms of building customer loyalty with its alcohol offerings,” Decker said. “There are many steps other restaurants can take to improve their alcoho

Hot Growth Companies For 2017: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, non-cyclical consumer goods & services shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Medifast Inc (NYSE: MED), down 5 percent, and Bridgford Foods Corporation (NASDAQ: BRID), down 6 percent.

Hot Growth Companies For 2017: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Nordstrom, Inc. (NYSE: JWN) was down, falling around 7 percent to $49.15 after the company reported weaker-than-expected results for its fourth quarter on Thursday.

  • [By Micheal Brown]

    Nordstrom (JWN) is a high end department store that is well known in the United States of America. It was founded by John W. Nordstrom and Carl F. Wallin in the year 1901. It began as a shoe retail store but has expanded over the years to retailing clothing’s, fragrances, accessories, handbags, jewelry and cosmetics.

    In the first quarter of this year, Nordstrom had amazing miss and ugly guidance reduction; its stock even plunged low about 30% in the last month. It was reported in the first quarter of the year that Nordstrom had earnings of 26 cents per share versus forecasts for 46 cents per share. Its sales were totaled to be $3.19 billion compared to the $3.28 billion which had earlier been estimated. Comparable-store sales fell 1.7%. For the remainder of the year, Nordstrom now foresees earnings of about $2.50 to $2.70 cents a share, down from $3.10 to $3.65 a share previously. 

  • [By WWW.THESTREET.COM]

    One theme that’s become apparent is that consumers are betting that a Trump tax cut will lead to more money in their pockets. That’s good news for the so-called “trade-up” stocks like Nordstrom (JWN) and Kohl’s (KSS) .

  • [By Ben Levisohn]

    Shares of Kohl’s have tumbled 16% to $43.04 at 11:28 a.m. today, while Macy’s (M) has dropped 2.6% to $40.56, and Nordstrom (JWN) has fallen 5.7% to $47.64.

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By Jim Robertson]

    I’m not going to dig deep into their financials, but trust me when I say we are not fans of Lululemon Athletica Inc. (LULU), The Kroger Co. (KR) and Nordstrom Inc. (JWN) right now As you can see with JWN, although the stock has done well of late, it’s clearly in a long-term downtrend, one I don’t think will end until the stock finds its way down below $30 per share. That’s a far cry from where it is now, but depending on what the rest of the markets do, it’s definitely achievable. However, we’re going to keep a bit of a shorter leash on this particular idea considering its recent strength.

Top Long Term Stocks To Own Right Now

This review updates my initial look at Costamare (NYSE:CMRE) from my July 28, 2016, article “Will Costamare Shipping Weather The Storm? An Update.”

Though I hope you will read the original linked article in full, my bottom line assessment and buy recommendation at the time were as follows:

The press release, which I have provided the link to, is well worth the read. Cutting to the chase, this company has continued to “deliver solid and profitable results” in a sector badly damaged by low container shipping rates. Yet as I predicted, the larger and more stable companies like CMRE and SSW would handle the downturn while their peers might not. Additionally, Costamare has taken steps to further insure its survival by extending its credit lines through refinancing existing loan facilities and entering into new loan agreements. It has also added to its fleet and has successfully extended long term charter agreements with reliable counter-parties that, as far as I’m concerned, bodes well for this company’s future.

Top Long Term Stocks To Own Right Now: EQT Corporation(EQT)

Advisors’ Opinion:

  • [By Joel South and Taylor Muckerman]

    In today’s segment, Joel South talks about an intriguing development from EQT Corp. (NYSE: EQT  ) and Green Field Services, where the companies drilled a multistage fracked natural gas well in the Marcellus shale using 100% field natural gas. Using natural gas from close wells instead ofdieselto power rigs could be another game changer as oil and gas companies continue to increase drilling efficiencies and thereby significantly lower costs.

  • [By Gary Jakacky]

    On the other hand, our economy shows more strength by the day. Oil prices remain stuck in a five year range. Natural gas prices are testing new lows: successful fracking techniques recently announced by EQT Corporation (EQT) in Seeking Alpha (10/17/2013 @ 2:29 PM on Market Currents) could cut over $1.5 billion from the costs of drilling for gas, as well as assuage "environmentalist" concerns about fracking. Fuel is a major cost for transportation companies. So maybe IYT can catch a third breath?

Top Long Term Stocks To Own Right Now: ConAgra Foods, Inc.(CAG)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Food Products industry and the overall market, CONAGRA FOODS INC’s return on equity significantly trails that of both the industry average and the S&P 500.

     

  • [By Laurie Kulikowski]

    Following 1) the recent sale of its Private Brands segment, 2) the announcement of the spin-off of Lamb Weston, 3) commentary around improving its margin structure in the Consumer segment, and 4) management’s recognition that the company has not raised its dividend in years, we think CAG is heading in the right direction. For income-oriented investors, note that CAG has a great deal of cash coming in from the Private Brands sale, and that management has stated its commitment to a strong dividend. As noted above, CAG is our best idea heading into new year. 

  • [By Monica Gerson]

     

    Darden Restaurants, Inc. (NYSE: DRI) is estimated to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion. ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion. Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.49 per share on revenue of $751.52 million. Micron Technology, Inc. (NASDAQ: MU) is expected to post a quarterly loss at $0.09 per share on revenue of $2.95 billion. McCormick & Company, Incorporated (NYSE: MKC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.06 billion. Constellation Brands, Inc. (NYSE: STZ) is expected to report its quarterly earnings at $1.51 per share. Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) is estimated to report its quarterly earnings at $0.18 per share on revenue of $356.41 million. Franklin Covey Co. (NYSE: FC) is expected to post its quarterly earnings at $0.08 per share on revenue of $49.89 million. Lindsay Corporation (NYSE: LNN) is projected to report its quarterly earnings at $0.99 per share on revenue of $148.43 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

  • [By Monica Gerson]

    ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.59 per share on revenue of $2.86 billion.

    PriceSmart, Inc. (NASDAQ: PSMT) is projected to post its quarterly earnings at $0.88 per share on revenue of $775.12 million.

  • [By Jon C. Ogg]

    ConAgraFoods Inc. (NYSE: CAG) was raised to Buy from Neutral at Goldman Sachs.

    E*TRADE Financial Corp. (NASDAQ: ETFC) was reiterated as Buy, but the price target was raised to $19.50 from $16.50, at Sterne Agee, making the third or fourth such price target upgrade in as many days, but what stands out here is that this appears to now be a “street-high” price target.

  • [By Michael Flannelly]

    JP Morgan analysts believe that consensus earnings estimates on ConAgra Foods, Inc. (CAG) have downside risk. As such, the analysts downgraded the packaged food manufacturer on Tuesday.

    The analysts downgraded CAG from “Overweight” to “Neutral” and see shares reaching $33. This price target suggests a slight upside to the stock’s Monday closing price of $32.09.

    ConAgra shares were down 20 cents, or 0.69%, during early morning trading on Tuesday. The stock is up 8.27% year-to-date.

Top Long Term Stocks To Own Right Now: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Familiar names on LVHI's roster include Toyota Motor Corp (ADR) (NYSE: TM), AstraZeneca plc (ADR) (NYSE: AZN) and GlaxoSmithKline plc (ADR) (NYSE: GSK). None of LVHI's holdings currently accounts for more than 2.73 percent of the ETF's weight.

  • [By James Brumley]

    Ditto for the gene-mapping mania that was sparked by the Roche (RHHBY) acquisition of Illumina and the GlaxoSmithKline (GSK) purchase of Human Genome Sciences. By the time the gene-mapping M&A trend became obviously hot, the trend was over.

Top Long Term Stocks To Own Right Now: Marsh & McLennan Companies, Inc.(MMC)

Advisors’ Opinion:

  • [By Reuters]

    Wendy Maeda/The Boston Globe via Getty Images NEW YORK — Walgreen is moving 120,000 employees to a private health insurance exchange from coverage provided directly from carriers, the company will announce Wednesday. The pharmacy chain will join 17 other large employers on the Aon Hewitt Corporate Health Exchange as part of a growing movement to offer employees fixed dollar amounts to purchase their own plans on such exchanges. The end-cost to employees depends on the plan chosen, but they typically get more options than under traditional arrangements. Private exchanges mimic the coverage mandated as part of the Affordable Care Act. Enrollment in the public exchanges starts Oct. 1. “What happens to employer contributions over time? Will they put in as much as they put in the past? These are unanswered questions but potential negatives,” says Paul Fronstin, a senior research associate with the Employee Benefit Research Institute. The benefit to Walgreen and other employers is unknown at this point, as their cost-savings aren’t clear. Of the 180,000 Walgreen (WAG) employees eligible for health care insurance, 120,000 opted for coverage for themselves and 40,000 family members. Another 60,000 employees, many of them working part-time, weren’t eligible for health insurance. Aon Hewitt (AON) says other participants in its program include retailer Sears Holding (SHLD) and Darden Restaurants (DRI). These new additions raise enrollment to 330,000 from 100,000 last year, and Aon Hewitt estimates enrollment will jump to 600,000 next year, a fivefold increase from 2012. By 2017, nearly 20 percent of employees nationwide could get their health insurance through a private exchange, according to Accenture Research (ACN). A recent report by the National Business Group on Health said that 30 percent of large employers are considering moving active employees to exchanges by 2015. Other major providers of private exchanges include Mercer, a division of Marsh & Mc

Top Long Term Stocks To Own Right Now: Statoil ASA(STO)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Should oil prices recover, we believe that deepwater drilling activity growth should lag growth in US shale activity, as project economics is generally better in US shales, and E&Ps involved in US shales are generally quicker to react. Deepwater activity is largely comprises a handful of companies (Petrobras (PBR), Statoil (STO), Total (TOT), Shell (RDS.A), BP (BP), ONGC, ExxonMobil (XOM) and Chevron (CVX)) and it is unlikely that these companies can meaningfully increase their rig demand in a short period of time to absorb the current oversupply. Thus, should oil prices rise in 2018, rig demand may increase, but likely not enough to tighten the market, given that supply equaling 43% of current working rig count is stacked and new supply equaling 25% of working rig count is under-construction and should be entering the market in the coming years. As a result, while we expect some improvement in rig utilization owing to rig retirements, it will unlikely be strong enough to meaningfully improve rates in 2018 above spot levels. Any demand increase in the interim could slow rig retirements materially, and be self-defeating. We thus are Sell rated on Transocean, Atwood and Noble.

  • [By Jayson Derrick]

    BP plc (ADR) (NYSE: BP), Royal Dutch Shell plc (ADR) (NYSE: RDS-A) (NYSE: RDS-B) and Statoil ASA(ADR) (NYSE: STO) are expected to outperform their peers by offering: 1) the greatest rate of change in cost reduction through technology and innovation, 2) upstream portfolios with an attractive risk to reward profile and 3) sufficient liquidity to invest in future growth.

  • [By Ben Levisohn]

    We believe that the equity market has neutralised much of its underweight energy positioning in 4Q/1Q, but was caught by the sharp rally in crude from end-January. Our base-case sees oil prices still higher by end-2016 (we see >$50/bbl), albeit with a choppy 2Q likely ahead. In this scenario a modest, rather than fully-fledged price-recovery we continue to place a lot of importance on self-help in driving ROE expansion (as opposed to relying simply on oil-leverage). Value-adjusted, we like the self-help stories around Total, Chevron, Statoil (STO), Royal Dutch Shell and Eni (E) in the group. Total is on the Citi European Focus list.

Top Long Term Stocks To Own Right Now: Lumber Liquidators Holdings, Inc(LL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Lumber Liquidators Holdings Inc (NYSE: LL) is projected to report a quarterly loss at $0.24 per share on revenue of $237.44 million.

    Fossil Group Inc (NASDAQ: FOSL) is estimated to post its quarterly earnings at $0.15 per share on revenue of $666.60 million.